Clinical Trials Logo

Clinical Trial Summary

A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness. Neonates will not be enrolled at any site for this study. The study data will derive from patient and donors past and present medical records, research records, and records about phone calls made as part of this research. The patient data will also be used from the records on visits.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06262451
Study type Observational
Source University of California, San Francisco
Contact Rachael Leigh Delacruz
Phone 4155148087
Email rachaelleigh.delacruz@ucsf.edu
Status Recruiting
Phase
Start date October 20, 2023
Completion date October 2032

See also
  Status Clinical Trial Phase
Terminated NCT04968951 - Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC) Early Phase 1
Withdrawn NCT03829878 - Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT) Phase 2
Recruiting NCT05826418 - Dietary Optimization of Microbiome Recovery Following Fecal Microbiota Transplantation N/A
Completed NCT04139577 - FMT In High-Risk Acute GVHD After ALLO HCT Phase 1
Withdrawn NCT04707222 - The Role of the Gut Microbiome in Modulating Physical Abilities in Humans N/A